Cleveland Clinic’s Medical Innovation Summit will bring together more than 2,250 of the brightest leaders from around the world to downtown Cleveland on Oct. 23 to 25 to focus on genomics and precision medicine advancements.
The agenda includes panels with top healthcare, industry and biotech leaders. Topics include: direct-to-consumer DNA testing, drug costs, next-generation genomic sequencing; the gene therapy and gene editing markets; and reimbursement strategies for genomic innovation.
Note to media: Cleveland Clinic is providing exclusive webcast access to members of the media interested in attending from afar. The live-stream broadcast link: cle.clinic/2wQj2xZ
Featured speakers include:
- Freda C. Lewis-Hall, M.D., Chief Medical Officer, Pfizer
- Craig Venter, Ph.D., Co-Founder, Executive Chairman, Human Longevity
- Eric Green, M.D., Ph.D., Director, National Human Genome Research Institute, NIH
- Jennifer Lee, M.D., Deputy Under Secretary for Health for Policy & Services, Veterans Affairs
- Mike Mahoney, President & CEO, Boston Scientific
- Anna Abram, Deputy Commissioner, FDA
- Kevin Lobo, Chairman & CEO, Stryker
Programs of special interest:
Community Healthcare Forum ( 23, 5:30 p.m.)
Toby Cosgrove, M.D., Cleveland Clinic CEO & President, and Seema Verma, Administrator of the Centers for Medicare and Medicaid Services, will join together for a Community Healthcare Forum: Our National Healthcare Transformation. The session will be moderated by Geraldo Rivera.
Top 10 Medical Innovations of 2018 (Oct. 25, 11:45 a.m.)
The summit will cap off with the annual Top 10 Medical Innovations list. Michael Roizen, M.D., and a team of leading physicians will announce the 10 medical innovations expected to have the greatest impact in the coming year.
State of Healthcare Innovation: Pharma Perspective (Oct. 23, 1:30 p.m.)
Moderated by CNBC’s Bertha Coombs, Dr. Cosgrove will be joined by pharmaceutical executives to examine recent policy impacts, cost reduction strategies, medical innovation funding and the overall health of drug research and innovation in the U.S.
Precision Medicine Policy: Can the Government Cure Cancer? (Oct. 24, 9:45 a.m.)
Representatives from FDA, National Institutes of Health and Veterans Affairs join with Brian Bolwell, M.D., Chair, Cleveland Clinic Taussig Cancer Institute, to discuss the latest government investments and the policies needed to push cancer to its tipping point.Impact sessions (Oct. 24, 1:45 p.m. – 5:00 p.m.)
Impact sessions in specialized areas include: the potential of the microbiome; artificial intelligence and decision-support technologies; customized implants and robotics; ethics and gene editing; deep brain stimulation; 3-D printing for surgery; customized orthopaedic surgeries; industry perspective on pharmacogenomics; and nutrigenomics.
Cleveland Medical Hackathon (Oct. 21-22)
This year’s summit will again share proximity with the 3rd Annual Cleveland Medical Hackathon, a coding and problem-solving competition that culminates on Oct. 22. Other partner events include Nursing Innovation Summit (Oct.23), Advanced Payment Summit (Oct. 24-25), and Meeting-of-the-Minds Summit (Oct. 23-25).
Now in its 15th year, the annual Medical Innovation Summit is organized by Cleveland Clinic Innovations, the development and commercialization arm of Cleveland Clinic.